TFF2 (trefoil factor 2) is a secreted peptide that serves multiple critical functions in gastrointestinal homeostasis and disease. Its primary function involves stabilizing the gastric mucus barrier through lectin-like interactions with the mucin MUC6, maintaining mucosal integrity and protecting against gastric acid damage 1. TFF2 acts as a paracrine signaling molecule, with decreased expression promoting inflammatory responses through FOXA2-mediated transcriptional regulation 2. The protein exhibits cellular repair properties, promoting intestinal epithelial cell migration and tight junction protein expression while inhibiting macrophage-mediated inflammation 3. In gastric pathophysiology, TFF2 is expressed during spasmolytic polypeptide-expressing metaplasia (SPEM), a precancerous condition arising from chief cell reprogramming following chr21 injury 4. TFF2 functions as a CXCR4 partial agonist, modulating immune cell activity including CD4+ T cell proliferation and neutrophil function 25. In pancreatic tissue, TFF2 defines transit-amplifying progenitor cells that protect against Kras-driven carcinogenesis 6. Clinically, TFF2 represents a therapeutic target for inflammatory bowel diseases and metabolic liver conditions, with fusion proteins showing promise in treating ulcerative colitis through enhanced mucosal repair mechanisms 3.